Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: The SAfrEIC-study

Thrombosis Research

Volumn 130, Issue 2, 2012, Pages 273-277

  Schutte, Aletta E ^a   Myburgh, Anélda ^a   Olsen, Michael H ^b   Eugen Olsen, Jesper ^c   Schutte, Rudolph ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b Mental Health Center Glostrup   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

African; cardiovascular; Caucasian; ethnicity; gender; suPAR

Indexed keywords

C REACTIVE PROTEIN; UROKINASE RECEPTOR;

ADULT; AGED; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PULSE WAVE; WINDKESSEL ARTERIAL COMPLIANCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BLOOD PRESSURE; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84864406495     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.034     Document Type: Article

References (29)

1. Writing Group Members D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, and T.B. Ferguson Heart disease and stroke statistics - 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 e21 e181
2. J.L. Xue, J.Z. Ma, T.A. Louis, and A.J. Collins Forecast of the number of patients with end-stage renal disease in the United States to the year 2010 J Am Soc Nephrol 12 2001 2753 2758 (Pubitemid 33115423)
3. S. Harding, M. Rosato, and A. Teyhan Trends for coronary heart disease and stroke mortality among migrants in England and Wales, 1979-2003: slow declines notable for some groups Heart 94 2008 463 470 (Pubitemid 351441403)
4. M. Thuno, B. Macho, and J. Eugen-Olsen suPAR: the molecular crystal ball Dis Markers 27 2009 157 172
5. S.R. Ostrowski, T.L. Katzenstein, T. Piironen, J. Gerstoft, B.K. Pedersen, and H. Ullum Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1 infected patients J Acquir Immune Defic Syndr 35 2004 337
6. S.R. Ostrowski, T. Piironen, G. Hoyer-Hansen, J. Gerstoft, B.K. Pedersen, and H. Ullum High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients J Acquir Immune Defic Syndr 39 2005 23
7. N. Sidenius, C.F.M. Sier, H. Ullum, B.K. Pedersen, A.C. Lepri, and F. Blasi Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection Blood 96 2000 4091 4095
8. J.F. Djoba Siawaya, M. Ruhwald, J. Eugen-Olsen, and G. Walzl Correlates for disease progression and prognosis during concurrent HIV/TB infection Int J Infect Dis 11 2007 289 299 (Pubitemid 46994763)
9. J. Eugen-Olsen, P. Gustafson, N. Sidenius, T.K. Fischer, J. Parner, and P. Aaby The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau Int J Tuberc Lung Dis 6 2002 686 692 (Pubitemid 34832148)
10. E. Henić, C. Borgfeldt, I.J. Christensen, B. Casslén, and G. Hoyer-Hansen Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer Clin Cancer Res 14 2008 5785 5793
11. K. Kofoed, J. Eugen-Olsen, J. Petersen, K. Larsen, and O. Andersen Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor Eur J Clin Microbiol Infect Dis 27 2008 375
12. J. Eugen-Olsen, O. Andersen, A. Linneberg, S. Ladelund, T.W. Hansen, and A. Langkilde Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population J Int Med 268 2010 296 308
13. K. Pawlak, M. Mysliwiec, and D. Pawlak The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients Thromb Res 122 2008 328 335 (Pubitemid 351888889)
14. K. Pawlak, D. Pawlak, and M. Mysliwiec Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients Thromb Res 120 2007 871 876 (Pubitemid 47418233)
15. K. Sliwa, D. Wilkinson, C. Hansen, L. Ntyintyane, K. Tibazarwa, and A. Becker Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study Lancet 371 2008 915 922 (Pubitemid 351375275)
16. M. Marfell-Jones, T. Olds, A. Steward, and L. Carter International standards of anthropometric assessment 2006 ISAK Potchefstroom, South Africa
17. B.P.M. Imholz, W. Wieling, G.A. van Montfrans, and K.H. Wesseling Fifteen years experience with finger arterial pressure monitoring Cardiovasc Res 38 2001 605 616
18. I. Guelen, B.E. Westerhof, G.L. van der Sar, G.A. van Montfrans, F. Kiemeneij, and K.H. Wesseling Validation of brachial artery pressure reconstruction from finger arterial pressure J Hypertens 26 2008 1321 1327
19. K.H. Wesseling, J.R. Jansen, J.J. Settels, and J.J. Schreuder Computation of aortic flow from pressure in humans using a nonlinear, three-element model J Appl Physiol 74 1993 2566 2573 (Pubitemid 23157090)
20. T. Sehestedt, S. Lyngbæk, J. Eugen-Olsen, J. Jeppesen, O. Anderson, and T.W. Hansen Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and caridovascular events Atherosclerosis 216 2011 237 243
21. T.Y. Wong, F.M.A. Islam, R. Klein, B.E.K. Klein, M.F. Cotch, and C. Castro Retinal vascular caliber, cardiovascular risk factors, and inflammation: the Multi-Ethnic Study of Atherosclerosis (MESA) Invest Ophthalmol Vis Sci 47 2006 2341 2350 (Pubitemid 351639814)
22. A.E. Schutte, D. van Vuuren, J.M. van Rooyen, H.W. Huisman, R. Schutte, and L. Malan Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study J Hum Hypertens 20 2006 850 859 (Pubitemid 44614067)
23. F.J. Olson, T. Thurison, M. Ryndel, G. Hoyer-Hansen, and B. Fagerberg Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability Clin Biochem 43 2010 124 130
24. H. Van der Vaart, D.S. Postma, W. Timens, and N.H. ten Hacken Acute effects of cigarette smoke on inflammation and oxidative stress: a review Thorax 59 2004 713 721 (Pubitemid 39061538)
25. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in atherosclerosis Physiol Rev 84 2004 1381 1478 (Pubitemid 39302636)
26. F.S. Facchini, C.B. Hollenbeck, J. Jeppesen, Y.D. Ida Chen, and G.M. Reaven Insulin resistance and cigarette smoking Lancet 339 1992 1128 1130
27. C.F. Sier, N. Sidenius, A. Mariani, G. Aletti, V. Agape, and A. Ferrari Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance Lab Invest 79 1999 717 722 (Pubitemid 29283425)
28. O. Andersen, J. Eugen-Olsen, K. Kofoed, J. Iversen, and S.B. Haugaard Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy J Med Virol 80 2008 209
29. R. Riisbro, I.J. Christensen, C. Hogdall, N. Brunner, and E. Hogdall Soluble urokinase plasminogen activator receptor measurements: influence of sample handling Int J Biol Markers 16 2001 233 239 (Pubitemid 34168381)